Dark Forest Capital Management LP Regenxbio Inc. Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $158,015 - $319,536
12,984 New
12,984 $273,000
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $239,738 - $302,072
13,914 Added 109.21%
26,655 $532,000
Q1 2023

May 12, 2023
BUY
$18.08 - $24.55 $230,357 - $312,791
12,741 New
12,741 $240,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $54,120 - $85,077
2,428 Added 26977.78%
2,437 $64,000
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $174 - $315
9 New
9 $0

Others Institutions Holding RGNX

# of Institutions
196
Shares Held
43M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $313M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email